BMLL — Bio Medica Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.88bn
- IN₹2.28bn
- IN₹430.90m
Annual cashflow statement for Bio Medica Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Preliminary |
| Net Income/Starting Line | 4.52 | 36.5 | 131 | 163 |
| Depreciation | ||||
| Non-Cash Items | -2.68 | -0.079 | -0.02 | 22.7 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 16.1 | -31.3 | -178 | -257 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 22.9 | 16.2 | -36.7 | -60.4 |
| Capital Expenditures | -17.1 | -15.3 | — | -28.1 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.199 | -0.118 | 3.39 | 7.01 |
| Sale of Fixed Assets | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -16.9 | -15.4 | 3.39 | -21.1 |
| Financing Cash Flow Items | -7.71 | -9.66 | -11.9 | -22.6 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -21.3 | -0.825 | 33.3 | 82.3 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -15.2 | 0.041 | -0.035 | 0.852 |